- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07474129
Serious Game Rehabilitation and Brain Plasticity in MS (REVEILLE)
March 11, 2026 updated by: Lille Catholic University
Brain Reorganization After Serious Game -Based Cognitive Rehabilitation in Multiple Sclerosis
This prospective, interventional, longitudinal, multicentre study aims to evaluate the impact of the "Serious game", an innovative cognitive remediation tool on brain reorganization in Multiple sclerosis patients, using functional Magnetic resonance imaging (MRI).
The serious game is a tool combining the motivational mechanisms of video games with cognitive remediation techniques.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Marie Paule LEBITASY
- Phone Number: +33320225741
- Email: urm@ghicl.net
Study Contact Backup
- Name: Lucile POISSON
- Phone Number: +33320225902
- Email: poisson.lucile@ghicl.net
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- People with relapsing-remitting or progressive MS defined according to the 2010 revised McDonald criteria [56]
- Cognitive complaints and deficits in at least one score on the initial neuropsychological examination (<5th percentile of the reference group)
- Aged between ≥ 18 and ≤ 65 years
- No defined relapse for at least 6 weeks
- At least 4 weeks since a corticosteroid bolus
- Patient with an internet connection
- Patient covered by social security
- Signed informed consent
Exclusion Criteria:
- Claustrophobia preventing MRI;
- Contraindication to MRI;
- Wearing fixed dental braces;
- Unable to receive oral and written information;
- Unable to use the software (due in particular to motor and/or sensory difficulties);
- Neurological or psychiatric comorbidity, other than MS and anxiety-depression syndrome,
- Patient with severe anxiety-depression syndrome (BDI-FS > 10),
- Pregnant or breastfeeding women
- Taking neuroleptic treatment
- Person under guardianship or curatorship
- Person deprived of liberty
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Serious Game-based cognitive rehabilitation in multiple sclerosis patients
Specifically for the study, patients will undergo two morphological and functional MRI scans (at rest and during activation) on the 3T MRI scanner at St Philibert Hospital at M0 and M4. In addition, two neuropsychological assessments will be carried out specifically at M0 and M4. The additional time required to complete these examinations is approximately 2½ hours. |
Specifically for the study, patients will undergo two morphological and functional MRI scans (at rest and during activation) on the 3T MRI scanner at St Philibert Hospital at M0 and M4.
In addition, two neuropsychological assessments will be carried out specifically at M0 and M4.
The additional time required to complete these examinations is approximately 2½ hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean activation of the brain region involved in the functional network
Time Frame: 5 months
|
The mean activation of each brain region involved in the functional network, will be measured using by functional MRI (fMRI) in patients with relapsing-remitting or progressive MS before and after Serious game.
For each participant, a generalized linear model will be applied with the activation paradigm as a regressor to generate individual brain activation maps related to the functional task.
The average activation values extracted from the regions of interest within the functional network will serve as the quantitative measure for statistical analyses.
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bruno LENNE, Hôpital Saint Philibert, GHICL
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
March 1, 2030
Study Registration Dates
First Submitted
March 11, 2026
First Submitted That Met QC Criteria
March 11, 2026
First Posted (Actual)
March 16, 2026
Study Record Updates
Last Update Posted (Actual)
March 16, 2026
Last Update Submitted That Met QC Criteria
March 11, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-P00132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.